Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting showing the performance of its Mercy Halo™ Ovarian Cancer screening test in a large cohort of asymptomatic, postmenopausal women.
The involvement of primary healthcare providers in epilepsy care can translate to early intervention, education about the condition, and coordination of care. However, many primary healthcare providers do not have sufficient training to care for people with epilepsy, leading to gaps in diagnosis and treatment.
The American Thoracic Society has announced the awardees of the 2024 Respiratory Health Awards. All 15 awardees will be formally recognized as part of the ATS 2024 International Conference in San Diego. The awards represent outstanding respiratory health contributions through various means, from research and diagnosis to education and advocacy.
The Centers for Medicare and Medicaid Services (CMS) recently announced changes to data access policies for researchers, substantially increasing costs and significantly limiting access for institutions.
The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER) studies, research to strengthen the rigor and quality of patient-centered CER and a project to implement the findings of PCORI-funded research into practice.
In a public commitment to become the most environmentally friendly health care organization in the nation and lead the industry to reduce its outsized impact on climate change, Penn Medicine has signed the ambitious Health Sector Climate Pledge, promising to significantly cut and, eventually, eliminate its carbon emissions by 2042.
State-of-the-art artificial intelligence systems known as large language models (LLMs) are poor medical coders, according to researchers at the Icahn School of Medicine at Mount Sinai.
Low-to-moderate drinking may not be protective against certain health conditions, and “safe” alcohol use guidelines may be substantially off base. These are among the implications of a review of studies that use a novel research method.
Liver inflammation, a common side-effect of cancers elsewhere in the body, has long been associated with worse cancer outcomes and more recently associated with poor response to immunotherapy. Now, a team led by researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania has found a big reason why.
A Rutgers Health study ties quitting to more hypertensive disorders but fewer premature deliveries and stillbirths.
Community research provider EmVenio Research and Prime Healthcare, an award-winning national health system, today announce their partnership to launch the EmVenio Research Center at Prime Healthcare. The partnership allows EmVenio to conduct research at Prime Healthcare hospitals and offer Prime's patients improved access to clinical research.
Mayo Clinic Platform continues to expand its distributed data network, Mayo Clinic Platform_Connect1, which now includes eight of the world's leading health systems across three continents: Seoul National University Hospital, SingHealth and UC Davis Health, which join Hospital Israelita Albert Einstein, Mayo Clinic, Mercy, Sheba Medical Center and University Health Network (UHN) as founding members.
JFK University Medical Center is among the top 9.4% in the nation with this designation
Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), have coauthored the first large-scale study that revealed racial disparities in treatment, survival, and access to care among patients with metastatic castration-sensitive prostate cancer (mCSPC) since the first novel hormonal therapy was approved in 2018.
Researchers at Case Western Reserve University’s School of Medicine believe they have found information that could lead to developing new treatment options for people with metastatic colorectal cancer.
“Support is the most important part of cancer treatment,” says El Paso resident Rosario De Anda, who was diagnosed with breast cancer. “When I started to feel that sense of hope, I began to lose the fear. It made me want to live and push forward.” she adds.
Showing results
1–20 of 25175
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
